Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 156

Xometry sources $25m

Existing backers BMW i Ventures and GE Ventures contributed to a round that took the total raised by the manufacturing services platform to $63m.

Jul 16, 2018

Otsuka works out Recor Medical acquisition

Existing backer Otsuka Holdings has agreed to acquire the remaining shares in portfolio company Recor, the creator of a device that treats hypertension.

Jul 16, 2018

Yahoo Japan cooks up $84m Dely deal

Yahoo Japan is paying $83.7m for a 45.6% stake in online recipe platform and portfolio company Dely, which has several other corporate backers.

Jul 13, 2018

Box melts for Butter.ai acquisition

The workplace search startup had raised about $3m from investors including Slack before being acquired by Box.

Jul 13, 2018

Medidata metes out $195m for Shyft Analytics

Clinical data analysis platform Shyft has agreed to a $195m purchase by investor Medidata that will also allow McKesson and UnitedHealth to exit.

Jul 12, 2018

Autodesk builds with Assemble Systems acquisition

Autodesk's Forge Fund has exited construction industry collaboration platform Assemble Systems in a purchase by its parent company.

Jul 12, 2018

AT&T to lift AlienVault in acquisition deal

Intel Capital and Teldat will exit the cybersecurity software provider in an acquisition by AT&T that is reportedly around the $600m mark.

Jul 12, 2018

Thoma Bravo takes majority stake in Centrify

Thoma Bravo is set to pay an undisclosed amount for a majority stake in Samsung, Docomo and Fortinet-backed cybersecurity software provider Centrify.

Jul 12, 2018

Visterra accepts $430m invitation from Otsuka

Merck & Co is one of the investors set to exit antibody drug developer Visterra after Otsuka Pharmaceutical agreed to buy the company for $430m.

Jul 12, 2018

UVC secures AMW exit

Unternehmertum Venture Capital Partners has agreed to sell its shares in AMW as part of an acquisition led by Hybio Pharmaceutical and Yunfeng Capital.

Jul 10, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here